1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Cesca Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System Autologous Bone Marrow Concentrate (aBMC), Placebo Control (diluted autologous peripheral blood) - Critical Limb Ischemia (CLI) | Phase 3 | Unknown | Cesca Therapeutics, Inc. | 224 | 2017-01-01 | 2016-07-28 |
Chronic Limb-Threatening Ischemia (1)
Dalip Sethi, PhD (1)